Schneider Susan 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Schneider Susan
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-11-08+180,000→ 180,000 totalExercise: $2.76Exp: 2031-11-08→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date.